Page last updated: 2024-08-22

1-hydroxypyrene and Cardiac Diseases

1-hydroxypyrene has been researched along with Cardiac Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bliss, R; Carmella, SG; Gross, M; Hatsukami, DK; Hecht, SS; Joseph, AM; Lando, H; Le, CT; Murphy, SE	1

Trials

1 trial(s) available for 1-hydroxypyrene and Cardiac Diseases

Article	Year
Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2008, Volume: 10, Issue:3 Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Carbon Monoxide; Cotinine; F2-Isoprostanes; Female; Fibrinogen; Glucuronides; Heart Diseases; Humans; Male; Middle Aged; Nitrosamines; Pyrenes; Pyridines; Smoking; Smoking Cessation; Smoking Prevention	2008

Article

Year

Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2008, Volume: 10, Issue:3

Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Carbon Monoxide; Cotinine; F2-Isoprostanes; Female; Fibrinogen; Glucuronides; Heart Diseases; Humans; Male; Middle Aged; Nitrosamines; Pyrenes; Pyridines; Smoking; Smoking Cessation; Smoking Prevention

2008